biOasis Technologies Ord Shs BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

GREY:BIOAF - Post by User

biOasis Technologies Ord Shs > Tomorrow is Rare Disease Day...

<< Previous

Bullboard Posts

Next >>

Post by prophetoffactzon Feb 27, 2023 7:32pm

217 Views

Post# 35308429

Tomorrow is Rare Disease Day...

@BioasisUS

 				As we approach #RareDiseaseDay, we're reminded of the need for innovative treatments for these often-neglected conditions. At Bioasis, we're proud to be working towards that goal by developing cutting-edge therapies for rare brain disorders. 

<< Previous

Bullboard Posts

Next >>

Cannabix advances marijuana breathalyzer tech